<?xml version="1.0"?>
<rss version="2.0" xmlns:blogChannel="http://backend.userland.com/blogChannelModule">
	<channel>
		<title>Medscape Nephrology Headlines</title>
		<link>http://www.medscape.com/nephrology?src=rss</link>
		<description>Latest medical news, articles, and features from Medscape Nephrology</description>
		<image>
			<url>http://images.medscape.com/pi/global/logos/mscp/logo-medscape110x30.gif</url>
			<title>Medscape Nephrology Headlines</title>
			<link>http://www.medscape.com/nephrology?src=rss</link>
		</image>
		<language>en-us</language>
		<copyright>Copyright 2009, Medscape</copyright>
		<pubDate>Tue, 24 Nov 2009 22:38:57 EST</pubDate>
		<managingEditor>nephrologyeditor@medscape.net</managingEditor>
		<webMaster>medscapecustomersupport@webmd.net (Medscape Customer Support)</webMaster>

		<item>
			<title>Acute Phosphate Nephropathy</title>
			<link>http://www.medscape.com/viewarticle/712534?src=rss</link>
			<description>Can drinking lots of water and other cautions prevent acute phosphate nephropathy after receiving oral sodium phosphate treatments?  &lt;br /&gt; &lt;i&gt;<![CDATA[Kidney International]]>&lt;/i&gt;</description>
			<category>Nephrology</category>
					<pubDate>Wed, 25 Nov 2009 12:00:00 EST</pubDate>
		</item>
		<item>
			<title>Frequency and Severity of Adverse Effects of Iodinated and Gadolinium Contrast Materials: Retrospective Review of 456,930 Doses</title>
			<link>http://www.medscape.com/viewarticle/711629?src=rss</link>
			<description>Both iodinated and gadolinium contrast agents are associated with a very low rate of adverse effects, and most adverse effects can be managed in the radiology department.   &lt;br /&gt; &lt;i&gt;<![CDATA[American Journal of Roentgenology]]>&lt;/i&gt;</description>
			<category>Pulmonary Medicine</category>
					<pubDate>Tue, 24 Nov 2009 12:00:00 EST</pubDate>
		</item>
		<item>
			<title>NCCN Clinical Practice Guidelines in Oncology  Kidney Cancer </title>
			<link>http://www.medscape.com/viewarticle/712614?src=rss</link>
			<description>Released in October 2009, the latest update to the NCCN Clinical Practice Guidelines in Oncology(TM) Kidney Cancer is presented.  &lt;br /&gt; &lt;i&gt;<![CDATA[Medscape Hematology-Oncology]]>&lt;/i&gt;</description>
			<category>Hematology-Oncology</category>
					<pubDate>Mon, 23 Nov 2009 16:37:45 EST</pubDate>
		</item>
		<item>
			<title>ESRD Bundling: How Will This Affect Small Dialysis Providers -- and Patients? A Report From ASN 2009.</title>
			<link>http://www.medscape.com/viewarticle/712649?src=rss</link>
			<description>Jeffrey S. Berns, MD, reports from ASN 2009 and discusses the effect of bundling all ESRD services into one prospective payment system as well as The Lancet retraction of the COOPERATE study.   &lt;br /&gt; &lt;i&gt;<![CDATA[Medscape Nephrology]]>&lt;/i&gt;</description>
			<category>Nephrology</category>
					<pubDate>Fri, 20 Nov 2009 13:52:03 EST</pubDate>
		</item>
		<item>
			<title>Three Major Trials Presented at ASN 2009</title>
			<link>http://www.medscape.com/viewarticle/712645?src=rss</link>
			<description>Jeffrey S. Berns, MD, reports from the floor of ASN Renal Week 2009 on 3 major trials, including an &quot;outstandingly done study&quot; on differing hemoglobin levels in patients with CKD and type 2 diabetes.  &lt;br /&gt; &lt;i&gt;<![CDATA[Medscape Nephrology]]>&lt;/i&gt;</description>
			<category>Nephrology</category>
					<pubDate>Fri, 20 Nov 2009 13:50:30 EST</pubDate>
		</item>
		<item>
			<title>Sen Grassley Questions Top Medical Schools About Ghostwriting</title>
			<link>http://www.medscape.com/viewarticle/712823?src=rss</link>
			<description>As part of his mission to see more financial transparency in medicine, Sen Grassley has asked eight top US medical schools about their policies on ghostwriting.  &lt;br /&gt; &lt;i&gt;<![CDATA[Heartwire]]>&lt;/i&gt;</description>
			<category>Cardiology</category>
					<pubDate>Fri, 20 Nov 2009 13:48:39 EST</pubDate>
		</item>
		<item>
			<title>House Passes Medicare SGR Fix </title>
			<link>http://www.medscape.com/viewarticle/712775?src=rss</link>
			<description>The House passed a bill that would rewrite the controversial sustainable growth rate   formula and eliminate a 21.2% Medicare pay cut for physicians scheduled for 2010.  &lt;br /&gt; &lt;i&gt;<![CDATA[Medscape Medical News]]>&lt;/i&gt;</description>
			<category>Business of Medicine</category>
					<pubDate>Thu, 19 Nov 2009 17:11:22 EST</pubDate>
		</item>
		<item>
			<title>Declining Renal Function Linked to Worse Cardiovascular Outcomes</title>
			<link>http://www.medscape.com/viewarticle/712711?src=rss</link>
			<description>In individuals with or without kidney disease at baseline, declining kidney function was linked to a higher risk for heart failure, myocardial infarction, peripheral arterial disease, and early death.  &lt;br /&gt; &lt;i&gt;<![CDATA[Medscape Medical News]]>&lt;/i&gt;</description>
			<category>Nephrology</category>
					<pubDate>Thu, 19 Nov 2009 12:37:25 EST</pubDate>
		</item>
		<item>
			<title>ALLHAT Investigators Report 10-Year Follow-up and Stand by Diuretics as First-Step Antihypertensive Treatment</title>
			<link>http://www.medscape.com/viewarticle/712724?src=rss</link>
			<description>New data confirm the original conclusions: although amlodipine and lisinopril are not superior to chlorthalidone on any outcome, chlorthalidone is superior to them on 1 or more secondary endpoints.  &lt;br /&gt; &lt;i&gt;<![CDATA[Medscape Medical News]]>&lt;/i&gt;</description>
			<category>Neurology &amp; Neurosurgery</category>
					<pubDate>Thu, 19 Nov 2009 12:00:28 EST</pubDate>
		</item>
		<item>
			<title>New Senate Healthcare Reform Bill Features Public Option With Opt-Out</title>
			<link>http://www.medscape.com/viewarticle/712702?src=rss</link>
			<description>The Senate bill would cost $849 billion through 2019, but it would ultimately shave $127 billion off the federal deficit while reducing the number of uninsured by 31 million people.  &lt;br /&gt; &lt;i&gt;<![CDATA[Medscape Medical News]]>&lt;/i&gt;</description>
			<category>Business of Medicine</category>
					<pubDate>Wed, 18 Nov 2009 21:03:45 EST</pubDate>
		</item>
		<item>
			<title>A Case of Indurated Skin Rash in a Transplant Patient</title>
			<link>http://www.medscape.com/viewarticle/712264?src=rss</link>
			<description>A 32-year-old white woman presented to the transplant clinic with complaint of bilateral progressive erythematous rash of her thighs.  &lt;br /&gt; &lt;i&gt;<![CDATA[Medscape Nephrology]]>&lt;/i&gt;</description>
			<category>Nephrology</category>
					<pubDate>Wed, 18 Nov 2009 16:54:59 EST</pubDate>
		</item>
		<item>
			<title>Legius Syndrome Often Mistaken for Neurofibromatosis Type 1</title>
			<link>http://www.medscape.com/viewarticle/712643?src=rss</link>
			<description>Legius syndrome is genetically distinct but similar to neurofibromatosis and is characterized by cafe au lait macules, axillary freckling, and macrocephaly.  &lt;br /&gt; &lt;i&gt;<![CDATA[Medscape Medical News]]>&lt;/i&gt;</description>
			<category>Neurology &amp; Neurosurgery</category>
					<pubDate>Wed, 18 Nov 2009 15:20:55 EST</pubDate>
		</item>
		<item>
			<title>Characteristics and Outcomes of Trauma Patients With ICU Lengths of Stay 30 Days and Greater: A Seven-Year Retrospective Study</title>
			<link>http://www.medscape.com/viewarticle/711299?src=rss</link>
			<description>A 7-year retrospective study evaluated the characteristics and outcomes of trauma patients with lengths of stay 30 days and longer, focusing on predictors of prolonged stay and mortality.  &lt;br /&gt; &lt;i&gt;<![CDATA[Critical Care]]>&lt;/i&gt;</description>
			<category>General Surgery</category>
					<pubDate>Tue, 17 Nov 2009 12:00:00 EST</pubDate>
		</item>

</channel>
</rss>